155 related articles for article (PubMed ID: 22551916)
1. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.
Mikol J; Deslys JP; Zou WQ; Xiao W; Brown P; Budka H; Goutieres F
Clin Neuropathol; 2012; 31(3):127-34. PubMed ID: 22551916
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type.
Mizutani T
Acta Pathol Jpn; 1981 Nov; 31(6):903-22. PubMed ID: 7032195
[TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
Mitrova E; Belay G
Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
[TBL] [Abstract][Full Text] [Related]
5. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.
Douet JY; Huor A; Cassard H; Lugan S; Aron N; Mesic C; Vilette D; Barrio T; Streichenberger N; Perret-Liaudet A; Delisle MB; Péran P; Deslys JP; Comoy E; Vilotte JL; Goudarzi K; Béringue V; Barria MA; Ritchie DL; Ironside JW; Andréoletti O
Acta Neuropathol Commun; 2021 Aug; 9(1):145. PubMed ID: 34454616
[TBL] [Abstract][Full Text] [Related]
6. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
[TBL] [Abstract][Full Text] [Related]
7. Sporadic Creutzfeldt-Jakob Disease in a Young Girl With Unusually Long Survival.
D'Arcy CE; Bitnun A; Coulthart MB; D'Amour R; Friedman J; Knox JD; Rapoport A; Carter S; Widjaja E; Hazrati LN; Jansen GH
J Neuropathol Exp Neurol; 2019 Apr; 78(4):373-378. PubMed ID: 30856268
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.
Preusser M; Ströbel T; Gelpi E; Eiler M; Broessner G; Schmutzhard E; Budka H
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):413-6. PubMed ID: 16484658
[TBL] [Abstract][Full Text] [Related]
9. [Panencephalopathy of the Creutzfeldt-Jakob disease type].
Gertz HJ; Stoltenburg G; Cruz-Sanchez F; Lafuente J; Schopol R
Nervenarzt; 1988 Feb; 59(2):110-2. PubMed ID: 3283576
[TBL] [Abstract][Full Text] [Related]
10. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
[TBL] [Abstract][Full Text] [Related]
11. Familial Creutzfeldt-Jakob disease with extensive degeneration of white matter. Ultrastructure of peripheral nerve.
Vallat JM; Dumas M; Corvisier N; Leboutet MJ; Loubet A; Dumas P; Cathala F
J Neurol Sci; 1983 Oct; 61(2):261-75. PubMed ID: 6358417
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jacob disease].
Gurau C; Zeghoudi AC; Atlaoui-Rabia S; Charitanski D; Mallecourt J
Presse Med; 2005 Sep; 34(15):1080-1. PubMed ID: 16334885
[TBL] [Abstract][Full Text] [Related]
13. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic form of Creutzfeldt-Jakob disease with rapid course in 82-year-old man.
Nowacki P; Kulczycki J; Narolewska A; Grzelec H
Folia Neuropathol; 2000; 38(4):161-3. PubMed ID: 11693718
[TBL] [Abstract][Full Text] [Related]
15. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter.
Mizutani T; Okumura A; Oda M; Shiraki H
J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):103-15. PubMed ID: 7012278
[TBL] [Abstract][Full Text] [Related]
16. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease.
de Villemeur TB
Handb Clin Neurol; 2013; 112():1191-3. PubMed ID: 23622328
[TBL] [Abstract][Full Text] [Related]
18. Creutzfeldt-Jakob disease. Report of a case of the panencephalopathic type and experiences of a teaching hospital in Taiwan.
Su MS; Wang SJ; Chiang H; Wang JS; Tan YA; Fuh JL; Liu HC
Eur Neurol; 1993; 33(3):241-3. PubMed ID: 8467846
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
[TBL] [Abstract][Full Text] [Related]
20. [Creutzfeldt-Jakob disease in a dura transplant recipient: first observation in Austria].
Radbauer C; Hainfellner JA; Gaudernak T; Deecke L; Budka H
Wien Klin Wochenschr; 1998 Jul; 110(13-14):496-500. PubMed ID: 9746964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
